{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T09:37:24Z","timestamp":1693129044769},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1053\/j.gastro.2005.09.033","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T12:17:46Z","timestamp":1131625066000},"page":"1711-1719","source":"Crossref","is-referenced-by-count":5,"title":["Management of Nonsteroidal, Anti-inflammatory, Drug-Associated Dyspepsia"],"prefix":"10.1053","volume":"129","author":[{"given":"Samir","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"McQuaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2005.09.033_bib1","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1572-0241.2002.05905.x","article-title":"Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions","volume":"97","author":"Straus","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.11192","article-title":"Meta-analysis of dyspepsia and nonsteroidal anti-inflammatory drugs","volume":"49","author":"Ofman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2005.09.033_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF02065549","article-title":"Nonsteroidal anti-inflammatory drugs and dyspepsia in the elderly","volume":"40","author":"Talley","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2005.09.033_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1572-0241.2000.2126_1.x","article-title":"The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs","volume":"95","author":"Moayyedi","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004836-198904000-00009","article-title":"Dyspepsia in NSAID users","volume":"11","author":"Larkai","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib6","first-page":"3","article-title":"Prevalence of upper gastrointestinal symptoms in the general population","volume":"231","author":"Heading","year":"1999","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2005.09.033_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008469-199412002-00009","article-title":"Mechanisms of gastric mucosal damage","volume":"3","author":"Hawkey","year":"1994","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.gastro.2005.09.033_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","article-title":"Stratifying the risk of NSAID-related upper gastrointestinal clinical events","volume":"123","author":"Laine","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib9","first-page":"8","article-title":"NSAID induced gastrointestinal complications: the ARAMIS perspective\u20131997. Arthritis, Rheumatism, and Aging Medical Information System","volume":"51","author":"Singh","year":"1998","journal-title":"J Rheumatol Suppl"},{"key":"10.1053\/j.gastro.2005.09.033_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archinte.1996.00440130066007","article-title":"Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study","volume":"156","author":"Singh","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib11","first-page":"1153","article-title":"Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use","volume":"82","author":"Larkai","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.300.6721.368","article-title":"Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms","volume":"300","author":"Shallcross","year":"1990","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2005.09.033_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/003655201750313333","article-title":"Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease","volume":"36","author":"Voutilainen","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib14","first-page":"1289","article-title":"Features associated with painless peptic ulcer bleeding","volume":"92","author":"Wilcox","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib15","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3109\/00365528509089284","article-title":"Symptoms in patients with peptic ulcer and hematemesis and\/or melena related to the use of non-steroid anti-inflammatory drugs","volume":"20","author":"Mellem","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration","volume":"28","author":"Armstrong","year":"1987","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2005.09.033_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.163.1.3823455","article-title":"Peptic ulcer and gastric carcinoma","volume":"163","author":"Shaw","year":"1987","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2005.09.033_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiology.178.1.1984327","article-title":"Detection of gastric erosions","volume":"178","author":"Shaw","year":"1991","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2005.09.033_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/0003-4819-101-4-538","article-title":"Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study","volume":"101","author":"Dooley","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mge.2003.122","article-title":"Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia","volume":"57","author":"Rabeneck","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2005.09.033_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4065\/79.10.1264","article-title":"Complications of endoscopy of the upper gastrointestinal tract","volume":"79","author":"Wolfsen","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2005.09.033_bib22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1365-2036.2003.01646.x","article-title":"The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia","volume":"17","author":"Thomson","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2005.09.033_bib23","first-page":"825","article-title":"Open access gastroscopy findings are unrelated to the use of aspirin and non-steroidal anti-inflammatory drugs","volume":"47","author":"Mansfield","year":"1997","journal-title":"Br J Gen Pract"},{"key":"10.1053\/j.gastro.2005.09.033_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.2005.41465.x","article-title":"Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors","volume":"100","author":"Hawkey","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF02229641","article-title":"The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis","volume":"15","author":"Van Groenendael","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.gastro.2005.09.033_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/00912700122009935","article-title":"A look at the safety profile of over-the-counter naproxen sodium","volume":"41","author":"Bansal","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2005.09.033_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/009127009903900513","article-title":"The safety profile of nonprescription ibuprofen in multiple-dose use","volume":"39","author":"Kellstein","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2005.09.033_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/147323000203000311","article-title":"Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses","volume":"30","author":"Rampal","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1053\/j.gastro.2005.09.033_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.2003.018531","article-title":"Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials","volume":"63","author":"Zhang","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2005.09.033_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0895-4356(03)00255-5","article-title":"Risk of hospitalization for upper gastrointestinal tract bleeding","volume":"57","author":"Gallerani","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2005.09.033_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001648-200209000-00023","article-title":"Acetaminophen and upper gastrointestinal complications","volume":"13","author":"Werner","year":"2002","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2005.09.033_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00001648-200109000-00018","article-title":"Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs","volume":"12","author":"Garcia Rodriguez","year":"2001","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2005.09.033_bib33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","article-title":"Glucosamine and chondroitin for treatment of osteoarthritis","volume":"283","author":"McAlindon","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2005.09.033_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1053\/j.gastro.2005.09.033_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/00002512-200320140-00004","article-title":"Glucosamine","volume":"20","author":"Matheson","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1053\/j.gastro.2005.09.033_bib36","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0002-9343(99)00368-X","article-title":"Gastrointestinal safety profile of nabumetone","volume":"107","author":"Huang","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding","volume":"54","author":"Lewis","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2005.09.033_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pain.2004.07.004","article-title":"Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis","volume":"111","author":"Edwards","year":"2004","journal-title":"Pain"},{"key":"10.1053\/j.gastro.2005.09.033_bib39","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib42","volume":"Volume 2005","author":"Graham","year":"2005"},{"key":"10.1053\/j.gastro.2005.09.033_bib43","unstructured":"Pfizer. Food and Drug Administration: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. Volume 2005. Washington, DC, 2005."},{"key":"10.1053\/j.gastro.2005.09.033_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1365-2036.2002.01219.x","article-title":"Dyspepsia tolerability from the patients\u2019 perspective","volume":"16","author":"Goldstein","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2005.09.033_bib45","doi-asserted-by":"crossref","first-page":"R644","DOI":"10.1186\/ar1704","article-title":"Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.gastro.2005.09.033_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2005.09.033_bib47","first-page":"1876","article-title":"Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo","volume":"27","author":"Bensen","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1053\/j.gastro.2005.09.033_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jama.293.3.366","article-title":"Arthritis medicines and cardiovascular events\u2013\u201chouse of coxibs.\u201d","volume":"293","author":"Topol","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2005.09.033_bib49","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMc045711","article-title":"Cardiovascular toxicity of valdecoxib","volume":"351","author":"Ray","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjmed.2004.03.012","article-title":"Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam","volume":"117","author":"Singh","year":"2004","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib51","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1053\/j.gastro.2004.08.016","article-title":"Risks of clinically significant upper gastrointestinal events with etodolac and naproxen","volume":"127","author":"Weideman","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib52","first-page":"56","article-title":"An updated safety profile of etodolac in several thousand patients","volume":"10","author":"Schattenkirchner","year":"1990","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1053\/j.gastro.2005.09.033_bib53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/37.9.937","article-title":"Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment","volume":"37","author":"Hawkey","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.gastro.2005.09.033_bib54","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1016\/S0002-9343(99)00367-8","article-title":"Gastrointestinal safety profile of meloxicam","volume":"107","author":"Schoenfeld","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/41.1.72","article-title":"Helicobacter pylori infection in rheumatoid arthritis","volume":"41","author":"Ishikawa","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2005.09.033_bib56","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/0016-5085(92)90311-L","article-title":"Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury","volume":"102","author":"Loeb","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib57","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/0016-5085(91)90665-8","article-title":"Long-term nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection","volume":"100","author":"Graham","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/ard.61.7.641","article-title":"Helicobacter pylori does not play a part in the dyspeptic complaints of rheumatology patients receiving long term treatment with non-steroidal anti-inflammatory drugs","volume":"61","author":"Calvet","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2005.09.033_bib59","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/gut.34.12.1677","article-title":"Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis","volume":"34","author":"Goggin","year":"1993","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2005.09.033_bib60","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2005.09.033_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2005.09.033_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-119-4-199308150-00001","article-title":"Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group","volume":"119","author":"Graham","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-115-3-195","article-title":"Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial","volume":"115","author":"Agrawal","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib67","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","article-title":"Prevention of NSAID-induced gastric ulcer with misoprostol","volume":"2","author":"Graham","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2005.09.033_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009749209095074","article-title":"A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis","volume":"21","author":"Verdickt","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/j.gastro.2005.09.033_bib69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9343(87)90832-1","article-title":"Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage","volume":"83","author":"Caldwell","year":"1987","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib70","first-page":"2367","article-title":"Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients","volume":"91","author":"Miglioli","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib71","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/gut.51.3.329","article-title":"Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients","volume":"51","author":"Labenz","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2005.09.033_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2005.09.033_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib75","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","article-title":"Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers","volume":"160","author":"Agrawal","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib76","first-page":"A2452","article-title":"PPI based healing of NSAID associated ulcers in patients continuing NSAIDS (abstr)","volume":"95","author":"Goldstein","year":"2000","journal-title":"Am J Gastro"},{"key":"10.1053\/j.gastro.2005.09.033_bib77","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0016-5085(98)70541-4","article-title":"American Gastroenterological Association medical position statement","volume":"114","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib78","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2004.07.060","article-title":"Endoscopic evaluation of patients with dyspepsia","volume":"127","author":"Lieberman","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib79","first-page":"S3","article-title":"An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori","volume":"162","author":"Veldhuyzen van Zanten","year":"2000","journal-title":"CMAJ"},{"key":"10.1053\/j.gastro.2005.09.033_bib80","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1572-0241.2002.05536.x","article-title":"Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy","volume":"97","author":"Canga","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","article-title":"Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials","volume":"2","author":"Salas","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib82","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/0016-5085(88)90003-0","article-title":"Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief","volume":"94","author":"Archambult","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.09.033_bib83","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/gut.34.10.1458","article-title":"Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine","volume":"34","author":"Hawkey","year":"1993","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2005.09.033_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.09.033_bib85","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1572-0241.2004.30089.x","article-title":"Empiric treatment with high and standard dose of omeprazole in general practice","volume":"99","author":"Meineche-Schmidt","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib86","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1572-0241.2001.03861.x","article-title":"Management of heartburn in a large, randomized, community-based study","volume":"96","author":"Howden","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00042737-200012020-00011","article-title":"Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis","volume":"12","author":"van Zyl","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2005.09.033_bib88","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1572-0241.2002.05774.x","article-title":"Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine","volume":"97","author":"Campbell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.09.033_bib89","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1046\/j.1365-2036.2003.01762.x","article-title":"Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users\u2013a randomized trial","volume":"18","author":"Lai","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505019682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505019682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:20:44Z","timestamp":1683282044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508505019682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0016508505019682"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2005.09.033","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}